Norma E. Rivera-Martínez

ORCID: 0000-0002-6716-1234
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Antifungal resistance and susceptibility
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Fungal Infections and Studies
  • Hematological disorders and diagnostics
  • Sepsis Diagnosis and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Drug-Induced Ocular Toxicity
  • Cervical Cancer and HPV Research
  • Antibiotic Use and Resistance
  • Viral gastroenteritis research and epidemiology
  • Oral Health Pathology and Treatment
  • Virus-based gene therapy research
  • Dermatological and COVID-19 studies
  • Cardiac Arrest and Resuscitation
  • Microscopic Colitis
  • Influenza Virus Research Studies
  • Nail Diseases and Treatments
  • Histiocytic Disorders and Treatments
  • Pericarditis and Cardiac Tamponade
  • Drug-Induced Adverse Reactions
  • SARS-CoV-2 detection and testing
  • Clostridium difficile and Clostridium perfringens research
  • Colorectal and Anal Carcinomas

Hospitales Regionales de Alta Especialidad
2020-2024

Instituto Tecnológico de Oaxaca
2021-2022

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2013-2014

Mexican Social Security Institute
2006

Cathrine Axfors Andreas M. Schmitt Perrine Janiaud Janneke van ‘t Hooft Sherief Abd‐Elsalam and 89 more Ehab F. Abdo Benjamin S. Abella Javed Akram Ravi K. Amaravadi Derek Angus Yaseen M. Arabi Shehnoor Azhar Lindsey R. Baden Arthur W. Baker Leïla Belkhir Thomas Benfield Marvin A. H. Berrevoets Cheng‐Pin Chen Tsung‐Chia Chen Shu‐Hsing Cheng Chien‐Yu Cheng Wei‐Sheng Chung Yehuda Z. Cohen Lisa N. Cowan Olav Dalgård Fernando Fonseca de Almeida e Val Marcus Lacerda Gisely Cardoso de Melo Lennie Derde Vincent Dubée Anissa Elfakir Anthony Gordon Carmen Margarita Hernández‐Cardenas Thomas Hills Andy I. M. Hoepelman Yi-Wen Huang Bruno Igau Ronghua Jin Felipe Jurado-Camacho Khalid S. Khan Peter G. Kremsner Benno Kreuels Cheng-Yu Kuo Thuy Le Yi‐Chun Lin Wu-Pu Lin Tse-Hung Lin Magnus Nakrem Lyngbakken Colin McArthur Bryan J. McVerry Patricia Meza-Meneses Wuelton Marcelo Monteiro Susan C. Morpeth Ahmad Mourad Mark J. Mulligan Srinivas Murthy Susanna Naggie Shanti Narayanasamy Alistair Nichol Lewis A. Novack Sean M. O’Brien Nwora Lance Okeke Léna Perez Rogelio Pérez‐Padilla Laurent Perrin Arantxa Remigio-Luna Norma E. Rivera-Martínez Frank W. Rockhold Sebastián Rodríguez‐Llamazares Robert Rolfe Rossana Rosa Helge Røsjø Vanderson de Souza Sampaio Todd B. Seto Muhammad Shehzad Shaimaa Soliman Jason E. Stout Ireri Thirión-Romero Andrea B. Troxel Ting-Yu Tseng Nicholas Turner Robert J. Ulrich Stephen R. Walsh Steve Webb Jesper M. Weehuizen Maria Velinova Hon-Lai Wong Rebekah Wrenn Fernando G. Zampieri Wu Zhong David Moher Steven N. Goodman John P. A. Ioannidis Lars G. Hemkens

Abstract Background Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aimed estimate the effects of hydroxychloroquine and chloroquine survival in from all available RCT evidence, published unpublished. Methods: Rapid meta-analysis ongoing, completed, discontinued RCTs treatment for any patients (protocol: https://osf.io/QESV4/ )....

10.1101/2020.09.16.20194571 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-18

The progressive disseminated histoplasmosis (PDH) has been associated with severe disease and high risk of death among people living HIV (PLWHIV). Therefore, the purpose this multicenter, prospective, double-blinded study done in ten Mexican hospitals was to determine diagnostic accuracy detecting Histoplasma capsulatum antigen urine using IMMY ALPHA EIA kit (IAHE), clarus GM Enzyme Immunoassay (cHGEI IMMY) MiraVista Urine Antigen LFA (MVHUALFA); as well Hcp100 1281-1283220SCAR nested PCRs...

10.1371/journal.pntd.0009215 article EN cc-by PLoS neglected tropical diseases 2021-03-08

Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence HIV+ Men who have Sex with (MSM) been shown, despite introduction Highly Active Anti-Retroviral Therapy (HAART). Papillomavirus (HPV) infections are highly prevalent MSM recent studies shown high rates HPV-associated anal intraepithelial neoplasia (AIN) this population. In present study we determined prevalence nature HPV...

10.1186/s12879-014-0671-4 article EN cc-by BMC Infectious Diseases 2014-12-01

We evaluated clinical effectiveness of regdanvimab (CT-P59), a severe acute respiratory syndrome coronavirus 2 neutralizing monoclonal antibody, in reducing disease progression and recovery time patients with mild-to-moderate 2019 (COVID-19), primarily Alpha variant.This was phase 3 2/3 parallel-group, double-blind, randomized trial. Outpatients COVID-19 were to single-dose 40 mg/kg (n = 656) or placebo 659), alongside standard care. The primary endpoint up day 28 among "high-risk" patients....

10.1093/ofid/ofac406 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-08-01

Background The Histoplasma urine antigen (HUAg) is the preferred method to diagnose progressive disseminated histoplasmosis (PDH) in HIV patients. In 2007, IMMY ALPHA EIA was approved for clinical on-site use, and therefore useful regions outside United States. However, ALPHA-HUAg considered inferior MVista-HUAg which only available on referral. We aim evaluate diagnostic accuracy of ALPHA-HUAg. Methodology/Principal findings conducted a multicenter, prospective, test study two secondary...

10.1371/journal.pntd.0006872 article EN cc-by PLoS neglected tropical diseases 2018-11-05

The 2009-2010 influenza A (H1N1pdm09) pandemic caused substantial morbidity and mortality among young patients; however, estimates have been confounded by regional differences in eligibility criteria inclusion of selected populations. In 2013-2014, H1N1pdm09 became North America's dominant seasonal strain. Our objective was to compare the baseline characteristics, resources, treatments with outcomes critically ill patients Mexican Canadian hospitals 2014 using consistent...

10.1097/ccm.0000000000001830 article EN Critical Care Medicine 2016-07-14

The novel coronavirus pandemic (COVID-19) represents a major public health problem and it is key to find treatment that reduces mortality. Our objective was estimate whether with 400 mg/day of Hydroxychloroquine for 10 days in-hospital mortality in subjects severe respiratory disease due COVID-19 compared placebo.A double-blind, randomized, placebo-controlled trial evaluate the safety efficacy by through an intention-to-treat analysis. Eligible study were adults aged more than 18 years...

10.1371/journal.pone.0257238 article EN cc-by PLoS ONE 2021-09-28

Fusarium species represent an opportunistic fungal pathogen. The data in Mexico about infections humans are scarce. Here, we present a retrospective series of patients with confirmed diagnosis fusariosis eight different hospitals from January 2010 to December 2019. proven was made according the European Organization for Research and Treatment Cancer Mycoses Study Group Education Consortium (EORT/MSG) criteria. A total 49 cases were identified our series. Most had burn injuries (49%), 37%...

10.1093/mmy/myad112 article EN Medical Mycology 2023-11-07

Phase III clinical trials have documented the efficacy of SARS-CoV-2 vaccines in preventing symptomatic COVID-19. Nonetheless, it is imperative to continue analyzing response different real-life studies. Our objective was evaluate effectiveness five hospitalized patients with COVID-19 during third outbreak Mexico dominated by Delta variant.A test-negative case-control study performed nine tertiary-care hospitals for We estimated odds ratios (OR) adjusted variables related a priori likelihood...

10.3390/vaccines11121779 article EN cc-by Vaccines 2023-11-28

ABSTRACT The novel coronavirus pandemic (COVID–19) represents a major public health problem due to its rapid spread and ability generate severe pneumonia. Thus, it is essential find treatment that reduces mortality. Our objective was estimate whether with 400 mg/day of Hydroxychloroquine for 10 days in-hospital mortality in subjects respiratory disease COVID-19 compared placebo. Material methods A double-blind, randomized, placebo-controlled trial evaluate the safety efficacy by through an...

10.1101/2021.02.01.21250371 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-02-05

Invasive fungal infections (IFIs) affect >1.5 million people per year. Nevertheless, IFIs are usually neglected and underdiagnosed. should be considered as a public-health problem major actions taken to tackle them their associated costs. Aim To report the incidence of in four Mexican hospitals, describe economic cost with therapy impact adverse events such acute kidney injury (AKI), liver damage (LD), ICU stay. This was retrospective, transversal study carried-out hospitals. All occurring...

10.1016/j.bjid.2018.10.277 article EN cc-by-nc-nd The Brazilian Journal of Infectious Diseases 2018-09-01

Abstract Background Regdanvimab is a monoclonal antibody with activity against SARS-CoV-2. A Phase 2/3 study two parts currently ongoing and data up to Day 28 of Part 1 available while the from 1315 patients enrolled in 2 are expected June 2021. Methods This phase 2/3, randomized, parallel-group, placebo-controlled, double-blind aimed assess therapeutic efficacy regdanvimab outpatients mild moderate COVID-19, not requiring supplemental oxygen therapy. Patients aged >18 onset symptoms...

10.1093/ofid/ofab466.745 article EN cc-by Open Forum Infectious Diseases 2021-11-01

Abstract Objective: This study aims to outline Clostridioides difficile infection (CDI) trends and outcomes in Mexican healthcare facilities during the COVID-19 pandemic. Design: Observational of case series. Setting: Sixteen public hospitals private academic institutions across eight states Mexico from January 2016 December 2022. Patients: CDI patients. Methods: Demographic, clinical, laboratory data patients were obtained clinical records. Cases classified as community or...

10.1017/ice.2024.153 article EN Infection Control and Hospital Epidemiology 2024-10-21

In individuals with HIV/AIDS, 47% of the deaths are attributed to invasive fungal infections (IFIs), despite antiretroviral (ARV) therapy. This is a retrospective study carried out in Hospital Regional de Alta Especialidad Oaxaca (HRAEO), southwest Mexico, where IFIs that occurred during 2016⁻2017 described. A total 55 were included. Histoplasmosis (36%) and possible-IFIs neutropenic fever (20%) most frequent cases, followed by cryptococcosis (14%). The HIV/AIDS subpopulation corresponded 26...

10.3390/jof4030109 article EN cc-by Journal of Fungi 2018-09-09

Background Men who have sex with men (MSM) been identified as a high-risk group for anal cancer. HPV has found associated this neoplasia it in cervical Concurrent infection HIV may facilitate or accelerate the pathological consequences of infections. In Mexico, where cancer is major public health problem, little known about prevalence and role HIV-positive population MSM. Methods: We analysed 323 exudates from MSM, Clinic at Instituto Nacional de Ciencias Médicas y Nutrición ‘Salvador...

10.1071/shv10n6ab23 article EN Sexual Health 2013-01-01

Background Increasing global incidence of serious fungal infections (SFI) requires increasing access to high quality medical mycology education improve their identification and decrease associated mortality. Methods An online course was developed by two infectious diseases (ID) specialists. The aimed diagnosis SFI delivered from April-June 2019. consisted 9 interactive sessions every week. Sessions were streamed a hospital in Mexico local participants gather there Other connected...

10.1099/acmi.fis2019.po0195 article EN cc-by-nc Access Microbiology 2020-02-01
Coming Soon ...